nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Mitomycin—urinary bladder cancer	0.263	0.569	CiPCiCtD
Busulfan—Alkylating Activity—Thiotepa—urinary bladder cancer	0.199	0.431	CiPCiCtD
Busulfan—GSTM1—urinary bladder cancer	0.108	0.519	CbGaD
Busulfan—GSTP1—urinary bladder cancer	0.0996	0.481	CbGaD
Busulfan—GSTM1—Carboplatin—urinary bladder cancer	0.0506	0.254	CbGbCtD
Busulfan—GSTM1—Cisplatin—urinary bladder cancer	0.0432	0.217	CbGbCtD
Busulfan—GSTP1—Carboplatin—urinary bladder cancer	0.0366	0.184	CbGbCtD
Busulfan—GSTP1—Cisplatin—urinary bladder cancer	0.0312	0.157	CbGbCtD
Busulfan—GSTP1—Etoposide—urinary bladder cancer	0.0307	0.154	CbGbCtD
Busulfan—CYP3A4—Thiotepa—urinary bladder cancer	0.00444	0.0223	CbGbCtD
Busulfan—GSTA1—urine—urinary bladder cancer	0.00303	0.125	CbGeAlD
Busulfan—GSTM1—urine—urinary bladder cancer	0.00224	0.0926	CbGeAlD
Busulfan—GSTA2—urine—urinary bladder cancer	0.00219	0.0904	CbGeAlD
Busulfan—GSTP1—urine—urinary bladder cancer	0.00141	0.058	CbGeAlD
Busulfan—MGST2—prostate gland—urinary bladder cancer	0.00128	0.0529	CbGeAlD
Busulfan—CYP3A4—Etoposide—urinary bladder cancer	0.0012	0.00605	CbGbCtD
Busulfan—GSTA1—prostate gland—urinary bladder cancer	0.00109	0.045	CbGeAlD
Busulfan—MGST2—renal system—urinary bladder cancer	0.000873	0.036	CbGeAlD
Busulfan—CYP3A4—Doxorubicin—urinary bladder cancer	0.000821	0.00413	CbGbCtD
Busulfan—GSTM1—prostate gland—urinary bladder cancer	0.000805	0.0333	CbGeAlD
Busulfan—GSTA1—epithelium—urinary bladder cancer	0.0008	0.033	CbGeAlD
Busulfan—GSTA2—prostate gland—urinary bladder cancer	0.000786	0.0324	CbGeAlD
Busulfan—MGST2—Podofilox—Etoposide—urinary bladder cancer	0.000763	0.713	CbGdCrCtD
Busulfan—GSTA1—renal system—urinary bladder cancer	0.000742	0.0306	CbGeAlD
Busulfan—MGST2—female reproductive system—urinary bladder cancer	0.000699	0.0289	CbGeAlD
Busulfan—MGST2—vagina—urinary bladder cancer	0.000632	0.0261	CbGeAlD
Busulfan—GSTA1—female reproductive system—urinary bladder cancer	0.000594	0.0245	CbGeAlD
Busulfan—GSTA2—epithelium—urinary bladder cancer	0.000577	0.0238	CbGeAlD
Busulfan—CYP3A4—urine—urinary bladder cancer	0.000573	0.0237	CbGeAlD
Busulfan—GSTM1—renal system—urinary bladder cancer	0.000549	0.0227	CbGeAlD
Busulfan—GSTA2—renal system—urinary bladder cancer	0.000535	0.0221	CbGeAlD
Busulfan—GSTP1—prostate gland—urinary bladder cancer	0.000504	0.0208	CbGeAlD
Busulfan—GSTM1—female reproductive system—urinary bladder cancer	0.00044	0.0182	CbGeAlD
Busulfan—GSTA2—female reproductive system—urinary bladder cancer	0.000429	0.0177	CbGeAlD
Busulfan—GSTP1—seminal vesicle—urinary bladder cancer	0.000427	0.0176	CbGeAlD
Busulfan—MGST2—lymph node—urinary bladder cancer	0.000409	0.0169	CbGeAlD
Busulfan—GSTP1—epithelium—urinary bladder cancer	0.000371	0.0153	CbGeAlD
Busulfan—GSTP1—smooth muscle tissue—urinary bladder cancer	0.000357	0.0147	CbGeAlD
Busulfan—GSTP1—renal system—urinary bladder cancer	0.000344	0.0142	CbGeAlD
Busulfan—GSTP1—urethra—urinary bladder cancer	0.000338	0.0139	CbGeAlD
Busulfan—MGST2—Azacitidine—Gemcitabine—urinary bladder cancer	0.000308	0.287	CbGdCrCtD
Busulfan—GSTP1—female reproductive system—urinary bladder cancer	0.000275	0.0114	CbGeAlD
Busulfan—GSTM1—lymph node—urinary bladder cancer	0.000257	0.0106	CbGeAlD
Busulfan—GSTP1—vagina—urinary bladder cancer	0.000249	0.0103	CbGeAlD
Busulfan—GSTP1—lymph node—urinary bladder cancer	0.000161	0.00665	CbGeAlD
Busulfan—CYP3A4—renal system—urinary bladder cancer	0.00014	0.00579	CbGeAlD
Busulfan—CYP3A4—female reproductive system—urinary bladder cancer	0.000112	0.00463	CbGeAlD
Busulfan—GSTA1—NRF2 pathway—NQO1—urinary bladder cancer	0.000105	0.00221	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—GSTP1—urinary bladder cancer	0.000103	0.00216	CbGpPWpGaD
Busulfan—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000102	0.00214	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—NAT2—urinary bladder cancer	9.69e-05	0.00203	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—GSTM1—urinary bladder cancer	9.5e-05	0.00199	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—NAT2—urinary bladder cancer	9.43e-05	0.00197	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—NAT2—urinary bladder cancer	9.3e-05	0.00195	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—GSTP1—urinary bladder cancer	9.07e-05	0.0019	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.95e-05	0.00187	CbGpPWpGaD
Busulfan—GSTA2—Phase II conjugation—GSTP1—urinary bladder cancer	8.9e-05	0.00186	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—GSTP1—urinary bladder cancer	8.79e-05	0.00184	CbGpPWpGaD
Busulfan—GSTM1—Phase II conjugation—GSTP1—urinary bladder cancer	8.66e-05	0.00181	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—GSTM1—urinary bladder cancer	8.33e-05	0.00174	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	8.28e-05	0.00173	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—NCOR1—urinary bladder cancer	8.26e-05	0.00173	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.22e-05	0.00172	CbGpPWpGaD
Busulfan—GSTA2—Phase II conjugation—GSTM1—urinary bladder cancer	8.18e-05	0.00171	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—GSTM1—urinary bladder cancer	8.08e-05	0.00169	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—NAT2—urinary bladder cancer	8.02e-05	0.00168	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—NAT2—urinary bladder cancer	7.91e-05	0.00165	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—HPGDS—urinary bladder cancer	7.75e-05	0.00162	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—GSTP1—urinary bladder cancer	7.71e-05	0.00161	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—HPGDS—urinary bladder cancer	7.54e-05	0.00158	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—GSTT1—urinary bladder cancer	7.52e-05	0.00157	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—VHL—urinary bladder cancer	7.51e-05	0.00157	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—GSTT1—urinary bladder cancer	7.31e-05	0.00153	CbGpPWpGaD
Busulfan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	7.28e-05	0.00152	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	7.18e-05	0.0015	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—NQO1—urinary bladder cancer	7.12e-05	0.00149	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—GSTM1—urinary bladder cancer	7.09e-05	0.00148	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—NQO1—urinary bladder cancer	6.93e-05	0.00145	CbGpPWpGaD
Busulfan—GSTP1—Phase II conjugation—GSTM1—urinary bladder cancer	6.77e-05	0.00142	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	6.45e-05	0.00135	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—HPGDS—urinary bladder cancer	6.41e-05	0.00134	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	6.27e-05	0.00131	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	6.25e-05	0.00131	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—GSTT1—urinary bladder cancer	6.22e-05	0.0013	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—GSTP1—urinary bladder cancer	5.94e-05	0.00124	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—NQO1—urinary bladder cancer	5.89e-05	0.00123	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—GSTP1—urinary bladder cancer	5.78e-05	0.00121	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CREBBP—urinary bladder cancer	5.69e-05	0.00119	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTZ1—urinary bladder cancer	5.56e-05	0.00116	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	5.49e-05	0.00115	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—GSTM1—urinary bladder cancer	5.46e-05	0.00114	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NAT1—urinary bladder cancer	5.27e-05	0.0011	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTO2—urinary bladder cancer	5.27e-05	0.0011	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	5.23e-05	0.0011	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—GSTP1—urinary bladder cancer	5.21e-05	0.00109	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—GSTP1—urinary bladder cancer	5.07e-05	0.00106	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—GSTP1—urinary bladder cancer	5e-05	0.00105	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	4.98e-05	0.00104	CbGpPWpGaD
Busulfan—MGST2—Metabolism—UGT2B7—urinary bladder cancer	4.82e-05	0.00101	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—GSTM1—urinary bladder cancer	4.79e-05	0.001	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTZ1—urinary bladder cancer	4.72e-05	0.000989	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—PTGS2—urinary bladder cancer	4.66e-05	0.000975	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—GSTM1—urinary bladder cancer	4.51e-05	0.000945	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTO2—urinary bladder cancer	4.48e-05	0.000937	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NAT1—urinary bladder cancer	4.48e-05	0.000937	CbGpPWpGaD
Busulfan—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	4.46e-05	0.000933	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP4B1—urinary bladder cancer	4.34e-05	0.000908	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—RBX1—urinary bladder cancer	4.31e-05	0.000903	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CCND1—urinary bladder cancer	4.21e-05	0.000881	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—UGT2B7—urinary bladder cancer	4.1e-05	0.000857	CbGpPWpGaD
Busulfan—MGST2—Metabolism—SLC19A1—urinary bladder cancer	4.1e-05	0.000857	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	4.07e-05	0.000852	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PRSS3—urinary bladder cancer	3.99e-05	0.000835	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	3.97e-05	0.000831	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—GSTM1—urinary bladder cancer	3.96e-05	0.000829	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	3.92e-05	0.00082	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.91e-05	0.000817	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—EP300—urinary bladder cancer	3.87e-05	0.000811	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP4B1—urinary bladder cancer	3.69e-05	0.000772	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—SLC19A1—urinary bladder cancer	3.48e-05	0.000729	CbGpPWpGaD
Busulfan—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	3.42e-05	0.000715	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PRSS3—urinary bladder cancer	3.39e-05	0.00071	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—urinary bladder cancer	3.38e-05	0.000706	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	3.22e-05	0.000674	CbGpPWpGaD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	3.21e-05	0.000671	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTZ1—urinary bladder cancer	3.19e-05	0.000668	CbGpPWpGaD
Busulfan—MGST2—Metabolism—TYMP—urinary bladder cancer	3.19e-05	0.000668	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—KRAS—urinary bladder cancer	3.12e-05	0.000653	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTZ1—urinary bladder cancer	3.1e-05	0.00065	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTO2—urinary bladder cancer	3.03e-05	0.000633	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NAT1—urinary bladder cancer	3.03e-05	0.000633	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTO2—urinary bladder cancer	2.94e-05	0.000616	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NAT1—urinary bladder cancer	2.94e-05	0.000616	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CCNE1—urinary bladder cancer	2.9e-05	0.000606	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NAT2—urinary bladder cancer	2.89e-05	0.000604	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—SOD2—urinary bladder cancer	2.82e-05	0.00059	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—UGT2B7—urinary bladder cancer	2.77e-05	0.000579	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—TYMP—urinary bladder cancer	2.71e-05	0.000568	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—UGT2B7—urinary bladder cancer	2.69e-05	0.000563	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—GPX1—urinary bladder cancer	2.69e-05	0.000563	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—HRAS—urinary bladder cancer	2.65e-05	0.000555	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTZ1—urinary bladder cancer	2.64e-05	0.000552	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTO2—urinary bladder cancer	2.5e-05	0.000524	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NAT1—urinary bladder cancer	2.5e-05	0.000524	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP4B1—urinary bladder cancer	2.49e-05	0.000521	CbGpPWpGaD
Busulfan—MGST2—Metabolism—RRM2—urinary bladder cancer	2.49e-05	0.000521	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NAT2—urinary bladder cancer	2.45e-05	0.000514	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP4B1—urinary bladder cancer	2.42e-05	0.000507	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SLC19A1—urinary bladder cancer	2.35e-05	0.000492	CbGpPWpGaD
Busulfan—MGST2—Metabolism—HPGDS—urinary bladder cancer	2.31e-05	0.000483	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ENO2—urinary bladder cancer	2.31e-05	0.000483	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PRSS3—urinary bladder cancer	2.29e-05	0.00048	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SLC19A1—urinary bladder cancer	2.29e-05	0.000479	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—UGT2B7—urinary bladder cancer	2.29e-05	0.000479	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTT1—urinary bladder cancer	2.24e-05	0.000468	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PRSS3—urinary bladder cancer	2.23e-05	0.000467	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—ATM—urinary bladder cancer	2.23e-05	0.000466	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDK4—urinary bladder cancer	2.22e-05	0.000464	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	2.19e-05	0.000458	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	2.16e-05	0.000452	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—RRM2—urinary bladder cancer	2.12e-05	0.000443	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	2.08e-05	0.000434	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	2.08e-05	0.000434	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP4B1—urinary bladder cancer	2.06e-05	0.000431	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	2.05e-05	0.000429	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—HPGDS—urinary bladder cancer	1.96e-05	0.000411	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ENO2—urinary bladder cancer	1.96e-05	0.000411	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC19A1—urinary bladder cancer	1.95e-05	0.000407	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CREBBP—urinary bladder cancer	1.93e-05	0.000405	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—RB1—urinary bladder cancer	1.93e-05	0.000403	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTT1—urinary bladder cancer	1.9e-05	0.000398	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	1.9e-05	0.000397	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PRSS3—urinary bladder cancer	1.9e-05	0.000397	CbGpPWpGaD
Busulfan—Pharyngitis—Methotrexate—urinary bladder cancer	1.89e-05	0.000325	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—urinary bladder cancer	1.88e-05	0.000323	CcSEcCtD
Busulfan—Hepatobiliary disease—Epirubicin—urinary bladder cancer	1.88e-05	0.000323	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—urinary bladder cancer	1.88e-05	0.000322	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—urinary bladder cancer	1.88e-05	0.000322	CcSEcCtD
Busulfan—Pruritus—Gemcitabine—urinary bladder cancer	1.88e-05	0.000322	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	1.87e-05	0.000392	CbGpPWpGaD
Busulfan—Nausea—Thiotepa—urinary bladder cancer	1.87e-05	0.000321	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—urinary bladder cancer	1.87e-05	0.000321	CcSEcCtD
Busulfan—Weight decreased—Doxorubicin—urinary bladder cancer	1.87e-05	0.000321	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—urinary bladder cancer	1.87e-05	0.00032	CcSEcCtD
Busulfan—Feeling abnormal—Etoposide—urinary bladder cancer	1.86e-05	0.00032	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—urinary bladder cancer	1.86e-05	0.00032	CcSEcCtD
Busulfan—MGST2—Metabolism—NQO1—urinary bladder cancer	1.86e-05	0.000389	CbGpPWpGaD
Busulfan—Agranulocytosis—Epirubicin—urinary bladder cancer	1.86e-05	0.000319	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—urinary bladder cancer	1.85e-05	0.000318	CcSEcCtD
Busulfan—Gastrointestinal pain—Etoposide—urinary bladder cancer	1.85e-05	0.000318	CcSEcCtD
Busulfan—Pruritus—Fluorouracil—urinary bladder cancer	1.84e-05	0.000316	CcSEcCtD
Busulfan—Infestation—Doxorubicin—urinary bladder cancer	1.84e-05	0.000316	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—urinary bladder cancer	1.84e-05	0.000316	CcSEcCtD
Busulfan—GSTA2—Metabolism—TYMP—urinary bladder cancer	1.83e-05	0.000384	CbGpPWpGaD
Busulfan—Hypersensitivity—Cisplatin—urinary bladder cancer	1.82e-05	0.000312	CcSEcCtD
Busulfan—Bradycardia—Epirubicin—urinary bladder cancer	1.82e-05	0.000312	CcSEcCtD
Busulfan—Diarrhoea—Gemcitabine—urinary bladder cancer	1.81e-05	0.000311	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—urinary bladder cancer	1.81e-05	0.000311	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—urinary bladder cancer	1.8e-05	0.00031	CcSEcCtD
Busulfan—Urticaria—Etoposide—urinary bladder cancer	1.8e-05	0.000309	CcSEcCtD
Busulfan—Haemoglobin—Epirubicin—urinary bladder cancer	1.79e-05	0.000308	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—urinary bladder cancer	1.79e-05	0.000308	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—urinary bladder cancer	1.79e-05	0.000308	CcSEcCtD
Busulfan—Rhinitis—Epirubicin—urinary bladder cancer	1.79e-05	0.000307	CcSEcCtD
Busulfan—Abdominal pain—Etoposide—urinary bladder cancer	1.79e-05	0.000307	CcSEcCtD
Busulfan—Body temperature increased—Etoposide—urinary bladder cancer	1.79e-05	0.000307	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—urinary bladder cancer	1.79e-05	0.000307	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—urinary bladder cancer	1.78e-05	0.000306	CcSEcCtD
Busulfan—Diarrhoea—Fluorouracil—urinary bladder cancer	1.78e-05	0.000306	CcSEcCtD
Busulfan—GSTM1—Metabolism—TYMP—urinary bladder cancer	1.78e-05	0.000373	CbGpPWpGaD
Busulfan—Asthenia—Cisplatin—urinary bladder cancer	1.77e-05	0.000304	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—urinary bladder cancer	1.77e-05	0.000304	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—urinary bladder cancer	1.77e-05	0.000304	CcSEcCtD
Busulfan—Urinary tract disorder—Epirubicin—urinary bladder cancer	1.76e-05	0.000303	CcSEcCtD
Busulfan—Haematuria—Doxorubicin—urinary bladder cancer	1.75e-05	0.000301	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—urinary bladder cancer	1.75e-05	0.000301	CcSEcCtD
Busulfan—Urethral disorder—Epirubicin—urinary bladder cancer	1.75e-05	0.0003	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	1.74e-05	0.000299	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—urinary bladder cancer	1.74e-05	0.000298	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—urinary bladder cancer	1.73e-05	0.000297	CcSEcCtD
Busulfan—Sinusitis—Doxorubicin—urinary bladder cancer	1.73e-05	0.000296	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—urinary bladder cancer	1.72e-05	0.000296	CcSEcCtD
Busulfan—Dizziness—Fluorouracil—urinary bladder cancer	1.72e-05	0.000296	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—urinary bladder cancer	1.72e-05	0.000295	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—urinary bladder cancer	1.72e-05	0.000295	CcSEcCtD
Busulfan—Chills—Methotrexate—urinary bladder cancer	1.71e-05	0.000294	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	1.71e-05	0.000358	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN2A—urinary bladder cancer	1.69e-05	0.000355	CbGpPWpGaD
Busulfan—Diarrhoea—Cisplatin—urinary bladder cancer	1.69e-05	0.00029	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—urinary bladder cancer	1.69e-05	0.00029	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	1.69e-05	0.000353	CbGpPWpGaD
Busulfan—Alopecia—Methotrexate—urinary bladder cancer	1.69e-05	0.000289	CcSEcCtD
Busulfan—Vomiting—Gemcitabine—urinary bladder cancer	1.69e-05	0.000289	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—urinary bladder cancer	1.68e-05	0.000289	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—urinary bladder cancer	1.67e-05	0.000287	CcSEcCtD
Busulfan—Rash—Gemcitabine—urinary bladder cancer	1.67e-05	0.000287	CcSEcCtD
Busulfan—Dermatitis—Gemcitabine—urinary bladder cancer	1.67e-05	0.000287	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—urinary bladder cancer	1.67e-05	0.000286	CcSEcCtD
Busulfan—Hypersensitivity—Etoposide—urinary bladder cancer	1.67e-05	0.000286	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—urinary bladder cancer	1.66e-05	0.000285	CcSEcCtD
Busulfan—Erythema—Methotrexate—urinary bladder cancer	1.66e-05	0.000285	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—urinary bladder cancer	1.66e-05	0.000285	CcSEcCtD
Busulfan—Headache—Gemcitabine—urinary bladder cancer	1.66e-05	0.000285	CcSEcCtD
Busulfan—GSTA2—Metabolism—NAT2—urinary bladder cancer	1.66e-05	0.000347	CbGpPWpGaD
Busulfan—Flushing—Epirubicin—urinary bladder cancer	1.66e-05	0.000284	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—urinary bladder cancer	1.66e-05	0.000284	CcSEcCtD
Busulfan—Vomiting—Fluorouracil—urinary bladder cancer	1.66e-05	0.000284	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—urinary bladder cancer	1.66e-05	0.000284	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—urinary bladder cancer	1.65e-05	0.000284	CcSEcCtD
Busulfan—Rash—Fluorouracil—urinary bladder cancer	1.64e-05	0.000282	CcSEcCtD
Busulfan—Dermatitis—Fluorouracil—urinary bladder cancer	1.64e-05	0.000282	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—urinary bladder cancer	1.64e-05	0.000281	CcSEcCtD
Busulfan—Headache—Fluorouracil—urinary bladder cancer	1.63e-05	0.00028	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—urinary bladder cancer	1.63e-05	0.00028	CcSEcCtD
Busulfan—Asthenia—Etoposide—urinary bladder cancer	1.62e-05	0.000279	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—urinary bladder cancer	1.62e-05	0.000279	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—urinary bladder cancer	1.62e-05	0.000278	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—urinary bladder cancer	1.62e-05	0.000278	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—urinary bladder cancer	1.61e-05	0.000277	CcSEcCtD
Busulfan—GSTM1—Metabolism—NAT2—urinary bladder cancer	1.61e-05	0.000337	CbGpPWpGaD
Busulfan—Mediastinal disorder—Epirubicin—urinary bladder cancer	1.61e-05	0.000276	CcSEcCtD
Busulfan—Back pain—Methotrexate—urinary bladder cancer	1.61e-05	0.000276	CcSEcCtD
Busulfan—Chills—Epirubicin—urinary bladder cancer	1.6e-05	0.000275	CcSEcCtD
Busulfan—Pruritus—Etoposide—urinary bladder cancer	1.6e-05	0.000275	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—urinary bladder cancer	1.6e-05	0.000274	CcSEcCtD
Busulfan—GSTA1—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000331	CbGpPWpGaD
Busulfan—Alopecia—Epirubicin—urinary bladder cancer	1.58e-05	0.000271	CcSEcCtD
Busulfan—Nausea—Gemcitabine—urinary bladder cancer	1.57e-05	0.00027	CcSEcCtD
Busulfan—Vomiting—Cisplatin—urinary bladder cancer	1.57e-05	0.00027	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—urinary bladder cancer	1.56e-05	0.000269	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—urinary bladder cancer	1.56e-05	0.000268	CcSEcCtD
Busulfan—Rash—Cisplatin—urinary bladder cancer	1.56e-05	0.000267	CcSEcCtD
Busulfan—Dermatitis—Cisplatin—urinary bladder cancer	1.56e-05	0.000267	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—urinary bladder cancer	1.55e-05	0.000267	CcSEcCtD
Busulfan—Erythema—Epirubicin—urinary bladder cancer	1.55e-05	0.000267	CcSEcCtD
Busulfan—MGST2—Metabolism—GSTP1—urinary bladder cancer	1.55e-05	0.000325	CbGpPWpGaD
Busulfan—Diarrhoea—Etoposide—urinary bladder cancer	1.55e-05	0.000266	CcSEcCtD
Busulfan—Nausea—Fluorouracil—urinary bladder cancer	1.55e-05	0.000266	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—urinary bladder cancer	1.54e-05	0.000265	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CXCL8—urinary bladder cancer	1.54e-05	0.000322	CbGpPWpGaD
Busulfan—Anaemia—Methotrexate—urinary bladder cancer	1.54e-05	0.000264	CcSEcCtD
Busulfan—Flushing—Doxorubicin—urinary bladder cancer	1.53e-05	0.000263	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—urinary bladder cancer	1.53e-05	0.000263	CcSEcCtD
Busulfan—Tension—Epirubicin—urinary bladder cancer	1.53e-05	0.000262	CcSEcCtD
Busulfan—GSTP1—Metabolism—TYMP—urinary bladder cancer	1.52e-05	0.000317	CbGpPWpGaD
Busulfan—Nervousness—Epirubicin—urinary bladder cancer	1.51e-05	0.000259	CcSEcCtD
Busulfan—Back pain—Epirubicin—urinary bladder cancer	1.5e-05	0.000258	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—urinary bladder cancer	1.5e-05	0.000257	CcSEcCtD
Busulfan—Dizziness—Etoposide—urinary bladder cancer	1.5e-05	0.000257	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—urinary bladder cancer	1.49e-05	0.000256	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—urinary bladder cancer	1.49e-05	0.000256	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—urinary bladder cancer	1.49e-05	0.000255	CcSEcCtD
Busulfan—Chills—Doxorubicin—urinary bladder cancer	1.48e-05	0.000254	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—urinary bladder cancer	1.48e-05	0.000253	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	1.47e-05	0.000308	CbGpPWpGaD
Busulfan—Nausea—Cisplatin—urinary bladder cancer	1.47e-05	0.000252	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—urinary bladder cancer	1.46e-05	0.000251	CcSEcCtD
Busulfan—Cough—Methotrexate—urinary bladder cancer	1.45e-05	0.000249	CcSEcCtD
Busulfan—Mental disorder—Doxorubicin—urinary bladder cancer	1.45e-05	0.000248	CcSEcCtD
Busulfan—MGST2—Metabolism—TYMS—urinary bladder cancer	1.44e-05	0.000302	CbGpPWpGaD
Busulfan—Convulsion—Methotrexate—urinary bladder cancer	1.44e-05	0.000247	CcSEcCtD
Busulfan—Vomiting—Etoposide—urinary bladder cancer	1.44e-05	0.000247	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—urinary bladder cancer	1.44e-05	0.000247	CcSEcCtD
Busulfan—Erythema—Doxorubicin—urinary bladder cancer	1.44e-05	0.000247	CcSEcCtD
Busulfan—Anaemia—Epirubicin—urinary bladder cancer	1.44e-05	0.000247	CcSEcCtD
Busulfan—GSTA2—Metabolism—RRM2—urinary bladder cancer	1.43e-05	0.000299	CbGpPWpGaD
Busulfan—Agitation—Epirubicin—urinary bladder cancer	1.43e-05	0.000245	CcSEcCtD
Busulfan—Rash—Etoposide—urinary bladder cancer	1.43e-05	0.000245	CcSEcCtD
Busulfan—Dermatitis—Etoposide—urinary bladder cancer	1.43e-05	0.000245	CcSEcCtD
Busulfan—MGST2—Metabolism—GSTM1—urinary bladder cancer	1.43e-05	0.000298	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NCOR1—urinary bladder cancer	1.43e-05	0.000298	CbGpPWpGaD
Busulfan—Headache—Etoposide—urinary bladder cancer	1.42e-05	0.000243	CcSEcCtD
Busulfan—Myalgia—Methotrexate—urinary bladder cancer	1.41e-05	0.000243	CcSEcCtD
Busulfan—Chest pain—Methotrexate—urinary bladder cancer	1.41e-05	0.000243	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—urinary bladder cancer	1.41e-05	0.000243	CcSEcCtD
Busulfan—Tension—Doxorubicin—urinary bladder cancer	1.41e-05	0.000242	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	1.4e-05	0.000241	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—urinary bladder cancer	1.4e-05	0.00024	CcSEcCtD
Busulfan—GSTM1—Metabolism—RRM2—urinary bladder cancer	1.39e-05	0.000291	CbGpPWpGaD
Busulfan—Leukopenia—Epirubicin—urinary bladder cancer	1.39e-05	0.000239	CcSEcCtD
Busulfan—Back pain—Doxorubicin—urinary bladder cancer	1.39e-05	0.000239	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CDKN1A—urinary bladder cancer	1.38e-05	0.00029	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NAT2—urinary bladder cancer	1.37e-05	0.000287	CbGpPWpGaD
Busulfan—Confusional state—Methotrexate—urinary bladder cancer	1.37e-05	0.000235	CcSEcCtD
Busulfan—MGST2—Metabolism—GPX1—urinary bladder cancer	1.36e-05	0.000286	CbGpPWpGaD
Busulfan—Cough—Epirubicin—urinary bladder cancer	1.36e-05	0.000233	CcSEcCtD
Busulfan—Convulsion—Epirubicin—urinary bladder cancer	1.35e-05	0.000231	CcSEcCtD
Busulfan—Infection—Methotrexate—urinary bladder cancer	1.35e-05	0.000231	CcSEcCtD
Busulfan—Nausea—Etoposide—urinary bladder cancer	1.34e-05	0.000231	CcSEcCtD
Busulfan—Hypertension—Epirubicin—urinary bladder cancer	1.34e-05	0.00023	CcSEcCtD
Busulfan—MGST2—Metabolism—ERCC2—urinary bladder cancer	1.34e-05	0.00028	CbGpPWpGaD
Busulfan—Nervous system disorder—Methotrexate—urinary bladder cancer	1.33e-05	0.000228	CcSEcCtD
Busulfan—Anaemia—Doxorubicin—urinary bladder cancer	1.33e-05	0.000228	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—urinary bladder cancer	1.33e-05	0.000228	CcSEcCtD
Busulfan—GSTA2—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.000277	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.000277	CbGpPWpGaD
Busulfan—Myalgia—Epirubicin—urinary bladder cancer	1.32e-05	0.000227	CcSEcCtD
Busulfan—Chest pain—Epirubicin—urinary bladder cancer	1.32e-05	0.000227	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—urinary bladder cancer	1.32e-05	0.000227	CcSEcCtD
Busulfan—Agitation—Doxorubicin—urinary bladder cancer	1.32e-05	0.000227	CcSEcCtD
Busulfan—GSTA1—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	0.000276	CbGpPWpGaD
Busulfan—Anxiety—Epirubicin—urinary bladder cancer	1.32e-05	0.000226	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—EP300—urinary bladder cancer	1.32e-05	0.000276	CbGpPWpGaD
Busulfan—Skin disorder—Methotrexate—urinary bladder cancer	1.32e-05	0.000226	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	1.31e-05	0.000226	CcSEcCtD
Busulfan—Dry mouth—Epirubicin—urinary bladder cancer	1.29e-05	0.000222	CcSEcCtD
Busulfan—Anorexia—Methotrexate—urinary bladder cancer	1.29e-05	0.000222	CcSEcCtD
Busulfan—GSTM1—Metabolism—ENO2—urinary bladder cancer	1.29e-05	0.00027	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HPGDS—urinary bladder cancer	1.29e-05	0.00027	CbGpPWpGaD
Busulfan—Leukopenia—Doxorubicin—urinary bladder cancer	1.29e-05	0.000221	CcSEcCtD
Busulfan—GSTA2—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000269	CbGpPWpGaD
Busulfan—Confusional state—Epirubicin—urinary bladder cancer	1.28e-05	0.00022	CcSEcCtD
Busulfan—Oedema—Epirubicin—urinary bladder cancer	1.27e-05	0.000218	CcSEcCtD
Busulfan—Hypotension—Methotrexate—urinary bladder cancer	1.27e-05	0.000217	CcSEcCtD
Busulfan—Infection—Epirubicin—urinary bladder cancer	1.26e-05	0.000216	CcSEcCtD
Busulfan—MGST2—Metabolism—MTHFR—urinary bladder cancer	1.26e-05	0.000264	CbGpPWpGaD
Busulfan—Cough—Doxorubicin—urinary bladder cancer	1.26e-05	0.000215	CcSEcCtD
Busulfan—GSTM1—Metabolism—GSTT1—urinary bladder cancer	1.25e-05	0.000262	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—urinary bladder cancer	1.25e-05	0.000214	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—urinary bladder cancer	1.24e-05	0.000214	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—urinary bladder cancer	1.24e-05	0.000213	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—urinary bladder cancer	1.24e-05	0.000213	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—urinary bladder cancer	1.24e-05	0.000213	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	1.24e-05	0.000212	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—urinary bladder cancer	1.23e-05	0.000212	CcSEcCtD
Busulfan—Insomnia—Methotrexate—urinary bladder cancer	1.23e-05	0.00021	CcSEcCtD
Busulfan—GSTA1—Metabolism—TYMS—urinary bladder cancer	1.23e-05	0.000257	CbGpPWpGaD
Busulfan—Chest pain—Doxorubicin—urinary bladder cancer	1.22e-05	0.00021	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—urinary bladder cancer	1.22e-05	0.00021	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—urinary bladder cancer	1.22e-05	0.00021	CcSEcCtD
Busulfan—Anxiety—Doxorubicin—urinary bladder cancer	1.22e-05	0.000209	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	1.22e-05	0.000209	CcSEcCtD
Busulfan—GSTA1—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	0.000254	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	0.000254	CbGpPWpGaD
Busulfan—Anorexia—Epirubicin—urinary bladder cancer	1.21e-05	0.000208	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—urinary bladder cancer	1.21e-05	0.000207	CcSEcCtD
Busulfan—Somnolence—Methotrexate—urinary bladder cancer	1.21e-05	0.000207	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—urinary bladder cancer	1.2e-05	0.000206	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—urinary bladder cancer	1.19e-05	0.000205	CcSEcCtD
Busulfan—Hypotension—Epirubicin—urinary bladder cancer	1.19e-05	0.000203	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—urinary bladder cancer	1.18e-05	0.000203	CcSEcCtD
Busulfan—GSTP1—Metabolism—RRM2—urinary bladder cancer	1.18e-05	0.000248	CbGpPWpGaD
Busulfan—Decreased appetite—Methotrexate—urinary bladder cancer	1.18e-05	0.000202	CcSEcCtD
Busulfan—Oedema—Doxorubicin—urinary bladder cancer	1.17e-05	0.000201	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	1.17e-05	0.000201	CcSEcCtD
Busulfan—Fatigue—Methotrexate—urinary bladder cancer	1.17e-05	0.000201	CcSEcCtD
Busulfan—Infection—Doxorubicin—urinary bladder cancer	1.17e-05	0.0002	CcSEcCtD
Busulfan—GSTA1—Metabolism—GPX1—urinary bladder cancer	1.16e-05	0.000243	CbGpPWpGaD
Busulfan—Pain—Methotrexate—urinary bladder cancer	1.16e-05	0.000199	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	1.16e-05	0.000198	CcSEcCtD
Busulfan—Nervous system disorder—Doxorubicin—urinary bladder cancer	1.15e-05	0.000198	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—urinary bladder cancer	1.15e-05	0.000197	CcSEcCtD
Busulfan—Insomnia—Epirubicin—urinary bladder cancer	1.15e-05	0.000197	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—urinary bladder cancer	1.15e-05	0.000197	CcSEcCtD
Busulfan—Skin disorder—Doxorubicin—urinary bladder cancer	1.14e-05	0.000196	CcSEcCtD
Busulfan—GSTA1—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	0.000238	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	1.14e-05	0.000238	CbGpPWpGaD
Busulfan—Dyspnoea—Epirubicin—urinary bladder cancer	1.13e-05	0.000194	CcSEcCtD
Busulfan—Somnolence—Epirubicin—urinary bladder cancer	1.13e-05	0.000194	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	1.12e-05	0.000235	CbGpPWpGaD
Busulfan—Anorexia—Doxorubicin—urinary bladder cancer	1.12e-05	0.000192	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—urinary bladder cancer	1.12e-05	0.000192	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—urinary bladder cancer	1.12e-05	0.000192	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—urinary bladder cancer	1.11e-05	0.00019	CcSEcCtD
Busulfan—Decreased appetite—Epirubicin—urinary bladder cancer	1.1e-05	0.000189	CcSEcCtD
Busulfan—Hypotension—Doxorubicin—urinary bladder cancer	1.1e-05	0.000188	CcSEcCtD
Busulfan—GSTP1—Metabolism—HPGDS—urinary bladder cancer	1.1e-05	0.000229	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ENO2—urinary bladder cancer	1.1e-05	0.000229	CbGpPWpGaD
Busulfan—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	1.1e-05	0.000188	CcSEcCtD
Busulfan—Fatigue—Epirubicin—urinary bladder cancer	1.09e-05	0.000188	CcSEcCtD
Busulfan—Pain—Epirubicin—urinary bladder cancer	1.08e-05	0.000186	CcSEcCtD
Busulfan—Constipation—Epirubicin—urinary bladder cancer	1.08e-05	0.000186	CcSEcCtD
Busulfan—Urticaria—Methotrexate—urinary bladder cancer	1.08e-05	0.000185	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—urinary bladder cancer	1.07e-05	0.000184	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—urinary bladder cancer	1.07e-05	0.000184	CcSEcCtD
Busulfan—GSTA1—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	0.000224	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	1.07e-05	0.000184	CcSEcCtD
Busulfan—GSTA2—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000224	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTT1—urinary bladder cancer	1.06e-05	0.000222	CbGpPWpGaD
Busulfan—Insomnia—Doxorubicin—urinary bladder cancer	1.06e-05	0.000182	CcSEcCtD
Busulfan—Dyspnoea—Doxorubicin—urinary bladder cancer	1.05e-05	0.00018	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—urinary bladder cancer	1.05e-05	0.000179	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—urinary bladder cancer	1.04e-05	0.000179	CcSEcCtD
Busulfan—GSTM1—Metabolism—NQO1—urinary bladder cancer	1.04e-05	0.000217	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.04e-05	0.000178	CcSEcCtD
Busulfan—Dyspepsia—Doxorubicin—urinary bladder cancer	1.03e-05	0.000177	CcSEcCtD
Busulfan—MGST2—Metabolism—PPARG—urinary bladder cancer	1.02e-05	0.000214	CbGpPWpGaD
Busulfan—Decreased appetite—Doxorubicin—urinary bladder cancer	1.02e-05	0.000175	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.01e-05	0.000174	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—urinary bladder cancer	1.01e-05	0.000174	CcSEcCtD
Busulfan—Urticaria—Epirubicin—urinary bladder cancer	1.01e-05	0.000173	CcSEcCtD
Busulfan—Pain—Doxorubicin—urinary bladder cancer	1e-05	0.000172	CcSEcCtD
Busulfan—Constipation—Doxorubicin—urinary bladder cancer	1e-05	0.000172	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—urinary bladder cancer	1e-05	0.000172	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—urinary bladder cancer	1e-05	0.000172	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—urinary bladder cancer	9.99e-06	0.000171	CcSEcCtD
Busulfan—MGST2—Metabolism—CREBBP—urinary bladder cancer	9.81e-06	0.000205	CbGpPWpGaD
Busulfan—Asthenia—Methotrexate—urinary bladder cancer	9.73e-06	0.000167	CcSEcCtD
Busulfan—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.67e-06	0.000166	CcSEcCtD
Busulfan—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.6e-06	0.000165	CcSEcCtD
Busulfan—Pruritus—Methotrexate—urinary bladder cancer	9.59e-06	0.000165	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—TP53—urinary bladder cancer	9.43e-06	0.000197	CbGpPWpGaD
Busulfan—Hypersensitivity—Epirubicin—urinary bladder cancer	9.35e-06	0.00016	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—urinary bladder cancer	9.32e-06	0.00016	CcSEcCtD
Busulfan—Body temperature increased—Doxorubicin—urinary bladder cancer	9.28e-06	0.000159	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—urinary bladder cancer	9.28e-06	0.000159	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—urinary bladder cancer	9.28e-06	0.000159	CcSEcCtD
Busulfan—Asthenia—Epirubicin—urinary bladder cancer	9.1e-06	0.000156	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.09e-06	0.00019	CbGpPWpGaD
Busulfan—Pruritus—Epirubicin—urinary bladder cancer	8.98e-06	0.000154	CcSEcCtD
Busulfan—Dizziness—Methotrexate—urinary bladder cancer	8.96e-06	0.000154	CcSEcCtD
Busulfan—GSTA2—Metabolism—GSTP1—urinary bladder cancer	8.91e-06	0.000186	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NQO1—urinary bladder cancer	8.83e-06	0.000185	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.82e-06	0.000185	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PPARG—urinary bladder cancer	8.69e-06	0.000182	CbGpPWpGaD
Busulfan—Diarrhoea—Epirubicin—urinary bladder cancer	8.68e-06	0.000149	CcSEcCtD
Busulfan—GSTM1—Metabolism—GSTP1—urinary bladder cancer	8.67e-06	0.000181	CbGpPWpGaD
Busulfan—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.65e-06	0.000148	CcSEcCtD
Busulfan—Vomiting—Methotrexate—urinary bladder cancer	8.62e-06	0.000148	CcSEcCtD
Busulfan—Rash—Methotrexate—urinary bladder cancer	8.55e-06	0.000147	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—urinary bladder cancer	8.54e-06	0.000147	CcSEcCtD
Busulfan—Headache—Methotrexate—urinary bladder cancer	8.49e-06	0.000146	CcSEcCtD
Busulfan—Asthenia—Doxorubicin—urinary bladder cancer	8.42e-06	0.000145	CcSEcCtD
Busulfan—Dizziness—Epirubicin—urinary bladder cancer	8.39e-06	0.000144	CcSEcCtD
Busulfan—GSTA1—Metabolism—CREBBP—urinary bladder cancer	8.34e-06	0.000175	CbGpPWpGaD
Busulfan—Pruritus—Doxorubicin—urinary bladder cancer	8.3e-06	0.000143	CcSEcCtD
Busulfan—GSTA2—Metabolism—TYMS—urinary bladder cancer	8.28e-06	0.000173	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTM1—urinary bladder cancer	8.19e-06	0.000171	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NCOR1—urinary bladder cancer	8.19e-06	0.000171	CbGpPWpGaD
Busulfan—Vomiting—Epirubicin—urinary bladder cancer	8.07e-06	0.000138	CcSEcCtD
Busulfan—GSTM1—Metabolism—TYMS—urinary bladder cancer	8.06e-06	0.000169	CbGpPWpGaD
Busulfan—Nausea—Methotrexate—urinary bladder cancer	8.05e-06	0.000138	CcSEcCtD
Busulfan—MGST2—Metabolism—PTGS2—urinary bladder cancer	8.04e-06	0.000168	CbGpPWpGaD
Busulfan—Diarrhoea—Doxorubicin—urinary bladder cancer	8.03e-06	0.000138	CcSEcCtD
Busulfan—Rash—Epirubicin—urinary bladder cancer	8e-06	0.000137	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—urinary bladder cancer	7.99e-06	0.000137	CcSEcCtD
Busulfan—GSTM1—Metabolism—NCOR1—urinary bladder cancer	7.96e-06	0.000167	CbGpPWpGaD
Busulfan—Headache—Epirubicin—urinary bladder cancer	7.95e-06	0.000136	CcSEcCtD
Busulfan—GSTA2—Metabolism—GPX1—urinary bladder cancer	7.84e-06	0.000164	CbGpPWpGaD
Busulfan—Dizziness—Doxorubicin—urinary bladder cancer	7.76e-06	0.000133	CcSEcCtD
Busulfan—GSTA2—Metabolism—ERCC2—urinary bladder cancer	7.7e-06	0.000161	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GPX1—urinary bladder cancer	7.63e-06	0.00016	CbGpPWpGaD
Busulfan—Nausea—Epirubicin—urinary bladder cancer	7.54e-06	0.000129	CcSEcCtD
Busulfan—GSTM1—Metabolism—ERCC2—urinary bladder cancer	7.49e-06	0.000157	CbGpPWpGaD
Busulfan—Vomiting—Doxorubicin—urinary bladder cancer	7.46e-06	0.000128	CcSEcCtD
Busulfan—Rash—Doxorubicin—urinary bladder cancer	7.4e-06	0.000127	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—urinary bladder cancer	7.39e-06	0.000127	CcSEcCtD
Busulfan—Headache—Doxorubicin—urinary bladder cancer	7.35e-06	0.000126	CcSEcCtD
Busulfan—GSTA2—Metabolism—MTHFR—urinary bladder cancer	7.23e-06	0.000151	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—MTHFR—urinary bladder cancer	7.04e-06	0.000147	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTEN—urinary bladder cancer	7.01e-06	0.000147	CbGpPWpGaD
Busulfan—Nausea—Doxorubicin—urinary bladder cancer	6.97e-06	0.00012	CcSEcCtD
Busulfan—GSTP1—Metabolism—TYMS—urinary bladder cancer	6.85e-06	0.000143	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTGS2—urinary bladder cancer	6.83e-06	0.000143	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTM1—urinary bladder cancer	6.77e-06	0.000142	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NCOR1—urinary bladder cancer	6.77e-06	0.000142	CbGpPWpGaD
Busulfan—MGST2—Metabolism—EP300—urinary bladder cancer	6.68e-06	0.00014	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GPX1—urinary bladder cancer	6.48e-06	0.000136	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ERCC2—urinary bladder cancer	6.37e-06	0.000133	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.11e-06	0.000128	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.03e-06	0.000126	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—MTHFR—urinary bladder cancer	5.98e-06	0.000125	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTEN—urinary bladder cancer	5.96e-06	0.000125	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPARG—urinary bladder cancer	5.87e-06	0.000123	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PPARG—urinary bladder cancer	5.71e-06	0.000119	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—EP300—urinary bladder cancer	5.68e-06	0.000119	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CREBBP—urinary bladder cancer	5.64e-06	0.000118	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.62e-06	0.000118	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.54e-06	0.000116	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CREBBP—urinary bladder cancer	5.48e-06	0.000115	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPARG—urinary bladder cancer	4.85e-06	0.000102	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CREBBP—urinary bladder cancer	4.66e-06	9.76e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS2—urinary bladder cancer	4.62e-06	9.66e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS2—urinary bladder cancer	4.49e-06	9.4e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTEN—urinary bladder cancer	4.02e-06	8.42e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTEN—urinary bladder cancer	3.92e-06	8.19e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—EP300—urinary bladder cancer	3.84e-06	8.03e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS2—urinary bladder cancer	3.82e-06	7.99e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.75e-06	7.84e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—EP300—urinary bladder cancer	3.73e-06	7.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.55e-06	7.43e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.55e-06	7.43e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTEN—urinary bladder cancer	3.33e-06	6.97e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.25e-06	6.8e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—EP300—urinary bladder cancer	3.17e-06	6.64e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.92e-06	6.12e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.76e-06	5.78e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.69e-06	5.63e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.15e-06	4.5e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.95e-06	4.07e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.68e-06	3.51e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.56e-06	3.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.56e-06	3.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.51e-06	3.16e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.25e-06	2.62e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.05e-06	2.19e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.72e-07	2.03e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.61e-07	2.01e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.61e-07	2.01e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.2e-07	1.93e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.03e-07	1.89e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.49e-07	1.78e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.89e-07	1.44e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.61e-07	1.38e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.42e-07	1.13e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.72e-07	9.89e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.5e-07	9.43e-06	CbGpPWpGaD
